Tradewinds Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $252 | Hold |
15
| – | – | ﹤0.01% | 589 |
|
|
2025
Q1 | $231 | Hold |
15
| – | – | ﹤0.01% | 620 |
|
|
2024
Q4 | $331 | Hold |
15
| – | – | ﹤0.01% | 620 |
|
|
2024
Q3 | $271 | Hold |
15
| – | – | ﹤0.01% | 583 |
|
|
2024
Q2 | $244 | Hold |
15
| – | – | ﹤0.01% | 558 |
|
|
2024
Q1 | $212 | Hold |
15
| – | – | ﹤0.01% | 522 |
|
|
2023
Q4 | $157 | Hold |
15
| – | – | ﹤0.01% | 447 |
|
|
2023
Q3 | $153 | Hold |
15
| – | – | ﹤0.01% | 475 |
|
|
2023
Q2 | $113 | Buy |
+15
| New | +$113 | ﹤0.01% | 455 |
|
|
2020
Q2 | – | Sell |
-465
| Closed | -$4K | – | 715 |
|
|
2020
Q1 | $4K | Hold |
465
| – | – | ﹤0.01% | 488 |
|
|
2019
Q4 | $5K | Hold |
465
| – | – | ﹤0.01% | 506 |
|
|
2019
Q3 | $3K | Hold |
465
| – | – | ﹤0.01% | 502 |
|
|
2019
Q2 | $4K | Hold |
465
| – | – | ﹤0.01% | 477 |
|
|
2019
Q1 | $7K | Hold |
465
| – | – | ﹤0.01% | 434 |
|
|
2018
Q4 | $7K | Hold |
465
| – | – | ﹤0.01% | 432 |
|
|
2018
Q3 | $10K | Hold |
465
| – | – | ﹤0.01% | 418 |
|
|
2018
Q2 | $11K | Buy |
465
+265
| +133% | +$6.27K | ﹤0.01% | 408 |
|
|
2018
Q1 | $3K | Hold |
200
| – | – | ﹤0.01% | 533 |
|
|
2017
Q4 | $4K | Hold |
200
| – | – | ﹤0.01% | 535 |
|
|
2017
Q3 | $4K | Hold |
200
| – | – | ﹤0.01% | 514 |
|
|
2017
Q2 | $7K | Buy |
+200
| New | +$7K | ﹤0.01% | 447 |
|
|
2015
Q4 | – | Sell |
-28
| Closed | -$2K | – | 681 |
|
|
2015
Q3 | $2K | Sell |
28
-104
| -79% | -$7.43K | ﹤0.01% | 553 |
|
|
2015
Q2 | $8K | Buy |
+132
| New | +$8K | 0.01% | 445 |
|
|
2014
Q1 | – | Sell |
-200
| Closed | -$8K | – | 647 |
|
|
2013
Q4 | $8K | Buy |
+200
| New | +$8K | 0.01% | 401 |
|